Liberty Dialysis was acquired by Fresenius Medical in February 2012.
Bain Capital Ventures seeded and co-founded Liberty Dialysis alongside management in 2002 and has been involved continuously with the company since that time. As Liberty has grown and required different types of financing, Bain Capital Ventures has helped the company meet its financing goals. In addition to investing in subsequent equity rounds, Bain Capital Ventures helped Liberty raise debt to finance the opening of de novo clinics, as well as to complete M&A. More recently, Bain Capital Ventures assisted in the company’s merger with Renal Advantage. The combined company is now the third largest dialysis provider in the US and serves over 19,000 patients in 32 states.